Thursday, January 23, 2025 11:22:27 AM
Truthfan,
Did you see the pipeline of this AI company which is using AI and omics for drug development? I am certain the two board members know very well about DCVax-L.
The company also has SoftBank as investor.
What I found interesting is that last August when I took the screen of the company's pipeline, oncology was listed as shown below. Now it is gone. It reminds me a company called EVOQ which is developing treatments using DCs. The company has collaborations with both Amgen and Gilead. At first, EVOQ also included oncology in its pipeline. But later, EVOQ only targets autoimmune diseases.
I feel like Oncology is totally LP's domain or empire.
https://www.insitro.com/leadership/roger-perlmutter-m-d-ph-d/
https://www.insitro.com/leadership/eli-casdin/
https://www.evoqtherapeutics.com/
https://www.europeanpharmaceuticalreview.com/news/178150/gilead-658-5m-immunotherapy-collaboration/
https://www.prnewswire.com/news-releases/evoq-therapeutics-and-amgen-expanding-collaboration-301724006.html
Did you see the pipeline of this AI company which is using AI and omics for drug development? I am certain the two board members know very well about DCVax-L.
The company also has SoftBank as investor.
What I found interesting is that last August when I took the screen of the company's pipeline, oncology was listed as shown below. Now it is gone. It reminds me a company called EVOQ which is developing treatments using DCs. The company has collaborations with both Amgen and Gilead. At first, EVOQ also included oncology in its pipeline. But later, EVOQ only targets autoimmune diseases.
I feel like Oncology is totally LP's domain or empire.
https://www.insitro.com/leadership/roger-perlmutter-m-d-ph-d/
https://www.insitro.com/leadership/eli-casdin/
https://www.evoqtherapeutics.com/
https://www.europeanpharmaceuticalreview.com/news/178150/gilead-658-5m-immunotherapy-collaboration/
https://www.prnewswire.com/news-releases/evoq-therapeutics-and-amgen-expanding-collaboration-301724006.html
